Al Jalila Children’s Specialty Hospital signs an agreement with Illumina

Al Jalila Children’s Specialty Hospital signs an agreement with Illumina

- The agreement will see Dubai-based hospital collaborate with a global leader in genomics to evaluate rapid whole genome sequencing (rWGS) use in critically ill, genetically underrepresented children across the Middle East

Dubai, UAE: Marking International Children's Day, Al Jalila Children's Specialty Hospital, the UAE’s first and only hospital dedicated to treating children and adolescents, signed an agreement with Illumina, a global leader in genomics. The agreement will see the two parties collaborate on the UAE’s first study to assess the impact of rapid genomic diagnosticson critically ill children within the region who may be diagnosed with a genetic disorder.

The ground-breaking collaboration centres around a two-year study at Al Jalila Children’s aimed at providing medical insights into the clinical use of rapid whole genome sequencing (rWGS) in the neonatal and paediatric care units as well as establishing it as a standard of care and first-tier comprehensive diagnostic tool for critically ill infants across the Middle East.

“This is an important partnership that could lead to significant breakthroughs in the way critically ill patients in the Middle East are treated,” said Dr. Abdulla Ibrahim Al Khayat, Chief Executive Officer of Al Jalila Children’s Specialty Hospital. “The agreement demonstrates our intent to work with